Stereotactic body radiation therapy (SBRT) in pancreatic cancer: Is it ready for prime time?

Journal of the Pancreas

Volumn 9, Issue 6, 2008, Pages 676-682

  Chang, Bryan W ^a   Saif, Muhammad Wasif ^a  

^a YALE CANCER CENTER   (United States)

Author keywords

Gemcitabine; Pancreatic neoplasms; Radiosurgery; Radiotherapy; Surgery

Indexed keywords

CAPECITABINE; FLUOROURACIL; GEMCITABINE;

CANCER GROWTH; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; DUODENUM PERFORATION; DUODENUM STENOSIS; DUODENUM ULCER; EDITORIAL; GUIDED IMAGERY; HUMAN; IONIZING RADIATION; NAUSEA; PAIN; PANCREAS CANCER; RADIATION DOSE; SAFETY; STENT; STEREOTACTIC BODY RADIATION THERAPY; STOMACH PARESIS; THROMBOSIS;

CLINICAL TRIALS AS TOPIC; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; PANCREATIC NEOPLASMS; RADIOSURGERY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TREATMENT OUTCOME;

EID: 56849093476     PISSN: None     EISSN: 15908577     Source Type: Journal    
DOI: None     Document Type: Editorial

References (20)

1. American Cancer Society. Cancer Facts and Figures 2008. Atlanta: American Cancer Society; 2008.
2. Moertel CG, Frytak S, Hahn RG et al. Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high-dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil) and high-dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group. Cancer 1981; 48(8):1705-10.
3. Krishnan S, Rana V, Janjan N et al. Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy. Cancer 2007;110(1):47-55.
4. Timmerman RD, Papiez L, McGarry R et al. Extracranial stereotactic radioablation: results of a phase I study in medically inoperable non-small cell lung cancer. Chest 2003;124:1946-55.
5. McGarry RC, Papiez L, Williams M et al. Stereotactic body radiation therapy of early-stage non-small cell lung carcinoma: Phase I study. Int J Radiat Oncol Biol Phys 2005;63(4):1010-5.
6. Timmerman RD, McGarry R, Yiannoutsos C, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 2006; 24:4833-4839.
7. Timmerman RD, Paulus R, Galvin J et al. Toxicity analysis of RTOG 0236 using stereotactic body radiation therapy to treat medically inoperable early-stage lung cancer patients. Int J Radiat Oncol Biol Phys 2007; 69 (3 Suppl):A-151,S86.
8. Lagerwaard FJ, Haasbeek CJ, Smit EF et al. Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2008;70(3):685-92.
9. Onishi H, Shirato H, Nagata Y et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol 2007;2(7 Suppl 3):S94-100.
10. Herfarth KK, Debus J, Lohr F et al. Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial. J Clin Oncol 2001;19(1):164-70.
11. Wulf J, Guckenberger M, Haedinger U et al. Stereotactic radiotherapy of primary liver cancer and hepatic metastases. Acta Oncol 2006;45:838-47.
12. Schefter TE, Kavanaugh BD, Timmerman RD et al. A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int J Radiat Oncol Biol Phys 2005;62(5):1371-8.
13. Kavanaugh BD, Schefter TE, Cardenes HR et al. Interim analysis of a prospective phase I/II trial of SBRT for liver metastases. Acta Oncol 2006;45(7):848-55.
14. Koong AC, Le QT, Ho A et al. Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 2004;58(4):1017-21.
15. Koong AC, Christofferson E, Le QT et al. Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 2005;63(2):320-3.
16. Schellenberg D, Goodman K, Lee F et al. Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 2008;72(3):678-86.
17. Hoyer M, Roed H, Sengelov L et al. Phase II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma. Radiother Oncol 2005;76:48-53.
18. Mahadevan A, Shanmugam L, Kaplan I et al. Fractionated radiosurgery for pancreas cancer. Int J Radiat Oncol Biol Phys 2007;69(3):S307.
19. Parikh SD, Burton SA, Heron DE et al. Stereotactic radiosurgery in patients with resected pancreatic carcinomas with positive margins. Int J Radiat Oncol Biol Phys 2008;72(1 Suppl):S271-2.
20. Lominska CE, Nasr NM, Silver NL et al. Salvage stereotactic radiosurgery for locally recurrent previously irradiated pancreatic cancer. Int J Radiat Oncol Biol Phys 2008; 72(1 Suppl):S276.